Julius Clinical Strengthens its European Capabilities by Expanding Operations in Poland
With a strong track record of over 15 clinical trials conducted in Poland during the last years, Julius Clinical recognizes the country's exceptional potential as a key clinical research hub in Europe. Poland offers a highly skilled workforce, a robust healthcare infrastructure, and a proven commitment to clinical research, making it an optimal destination for expanding the company's European footprint. The new affiliate will enable more efficient patient recruitment, improved site selection, and seamless regulatory compliance, ultimately accelerating the development of innovative therapies.
Martijn Wallert, CEO of Julius Clinical, said: "Expanding into Poland marks a strategic milestone for Julius Clinical. We are strengthening our presence in Eastern Europe, making Poland a central hub for our regional operations and expanding our ability to support clinical research across neighboring countries."
Radek Korba, Country Manager Poland, brings long-standing collaboration experience with Julius Clinical, ensuring a smooth transition for customers and partners. "Poland is a pivotal market in clinical research, and our local presence allows us to drive innovation while maintaining the highest standards of quality and compliance. We are excited to strengthen collaborations with investigators, healthcare institutions, and regulatory bodies to deliver impactful research," said Korba.
Julius Clinical's expansion into Poland aligns with its broader strategy of providing world-class, scientifically driven clinical research services globally. With this move, the company reinforces its commitment to accelerating medical breakthroughs through cutting-edge trial designs, access to diverse patient populations, and deep scientific expertise.
Julius Clinical is supported by Ampersand Capital Partners, a leading private equity firm with deep expertise in the life sciences and healthcare sectors.
About Julius Clinical
Founded in 2008 and headquartered in Zeist, The Netherlands, Julius Clinical is a leading CRO specializing in CNS, Cardio-Metabolic, Renal, and Rare Diseases. With over 380 clinical trials and 220,000+ subjects across 39 countries, Julius Clinical combines scientific leadership, operational excellence, and a global network of research sites to deliver tailored solutions for pharmaceutical, biotechnology, and academic partners.
For more information, visit https://www.juliusclinical.com or follow us on LinkedIn.
About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, The Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors.
For additional information, visit https://ampersandcapital.com or follow us on LinkedIn.
For more information on Julius Clinical services:
Email: businessdevelopment@juliusclinical.com
For more information on this press release, please contact:
Toni KovandjievaMarketing Manager, Julius ClinicalEmail: toni.kovandjieva@juliusclinical.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/julius-clinical-strengthens-its-european-capabilities-by-expanding-operations-in-poland-302383994.html
SOURCE Julius Clinical Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business of Fashion
an hour ago
- Business of Fashion
LVMH Slide Signals No Quick End to Big Luxury's Malaise
Amid a slew of bad news headlines at its top brands, from data leaks to labour exploitation, luxury giant LVMH tried hard to tell a good news story when it published its latest earnings report this week. Yes, sales were down 4 percent in the second quarter — with a 9 percent slide in the group's core fashion and leather goods division weighing heavily on overall performance — but that's not so bad in the current economic context, the group suggested. Sure, profits slid 15 percent in the first half, but the group has made significant steps to preserve margin by reigning in costs; even fashion show budgets are under the microscope, chief financial officer Cécile Cabanis told analysts. 'LVMH showed good resilience and maintained its powerful innovative momentum despite a disrupted geopolitical and economic environment,' the group said in a statement. ADVERTISEMENT Luxury analysts have grasped on to glimmers of hope. 'Boy it's rough… but won't get rougher' was the headline takeaway from HSBC's earnings rundown. The silver lining is that the latest quarter could prove a trough for luxury's bellwether stock and many of its peers in the space, the bank's note went on to say. But the path to recovery from luxury's bruising slump is still likely to be a long slog. HSBC isn't expecting a proper sales pick up until 2026. In other words, the big luxury downturn isn't over yet. A pandemic boom in luxury spending has given way to more cautious consumption amid a gloomy economic climate, particularly in the key China market, weighing heavily on sales at many brands. And the macroeconomic outlook for the rest of the year remains uncertain at best. In its latest results, LVMH flagged ongoing pressure on sales in Asia, a one-time driver of staggering luxury growth. In the US, President Trump's trade war remains an unpredictable headwind. At present, higher duties (which could come in as high as 30 percent for European-made luxury goods) are set to come into effect from Aug. 1. Trade negotiations to try and bring that number down are ongoing. But many of the industry's woes are self-inflicted and LVMH is no exception. 'I don't buy the explanation that this is just a macro issue,' said Bernstein analyst Luca Solca. Fashion's own goals include whopping price increases without corresponding product innovation, leading aspirational customers in particular to pull back. To be sure, not all luxury labels are suffering equally. LVMH arch-rival Hermès has proved solidly resilient, leading a cohort of businesses that appear to be beating the slump. Earlier this year, it supplanted LVMH as luxury's most valuable company. ADVERTISEMENT Top-end brands like Hermès and Brunello Cuccinelli, which reported sales up by 10.7 percent in the first-half, are less exposed to aspirational clients, but they have also taken a more cautious approach to price hikes, retaining a sense of trust in their value propositions. Other outperformers include Prada's trendy outlier Miu Miu. Clearer signs of the growing gap between luxury's winners and losers are set to emerge next week, when a flurry of luxury heavyweights, including Gucci-owner Kering, Hermès and Prada, are due to report. Analysts are anticipating a wide range of results.
NBC News
3 hours ago
- NBC News
Israel kills dozens in Gaza amid growing famine fueled by restricted aid flow
Israeli gunfire and airstrikes killed more than 50 Palestinians in Gaza on Saturday, including some who were waiting overnight for aid, according to local health officials, continuing a pattern that has drawn international criticism as the country's 'drip-feeding of aid' into the enclave continues to claim lives. Dr. Khalil Al-Daqran, a spokesperson for Gaza's Health Ministry, said at least 52 people were killed in Gaza so far this weekend, including those waiting in line for aid at the Zikim crossing with Israel, 'a number of starving children' and a group recovered in southern Khan Younis. In the Zikim area, at least a dozen were killed as they waited for aid trucks, according to The Associated Press. The Israel Defense Forces did not immediately respond to a request for comment. The latest killings near an aid distribution site come amid what many have described as Israel's 'drip-feeding of aid' into Gaza, a tactic that has contributed to more than 120 deaths from malnutrition and left a third of the population on the brink of starvation. The criticism is disputed by the Israeli military, which says it has allowed in an average of 70 trucks a day since May. But aid agencies say hundreds more trucks a day are necessary to feed Gaza's starving population. Five deaths due to malnutrition were recorded in Gaza in the last 24 hours, the Palestinian Health Ministry in the territory said on Saturday. At least 127 people, including 85 children, have died as a result of hunger in the enclave since Oct. 7, 2023, according to the ministry. Earlier this week, 25 countries, including Britain, Japan and a host of European nations, issued a joint statement insisting that the war in Gaza 'must end now.' The foreign ministers of the nations called the recent killings of Palestinians seeking aid 'horrific,' which Gaza's Health Ministry and the U.N. human rights office estimate to be over 800. The latest prior instance involved the killing of at least 67 people as they waited for U.N. aid trucks in northern Gaza on Sunday. Israel said its military had fired warning shots into the crowd to remove 'an immediate threat,' adding that casualty reports were inflated. The Israeli military, which controls the entry of all aid into the besieged enclave, blames the U.N. and other aid agencies for failing to distribute the supplies. U.N. spokesperson Stéphane Dujarric told reporters this week that there was 'a lack of willingness' from Israel to allow them to distribute aid. Israel has accused Hamas of stealing U.S.-funded aid, citing that as a main rationale, along with the U.S., for proposing a new armed, private aid operation. But an investigation by the U.S. Agency for International Development found ' no reports alleging Hamas ' benefited from U.S.-funded supplies. In a statement, the IDF said USAID's report ignores 'clear and explicit evidence that Hamas exploits humanitarian aid to sustain its fighting capabilities,' and criticizes the military 'for routing decisions made specifically to protect humanitarian staff and shipments.' 'The USAID report represents a striking example of biased framing,' the IDF said. 'Instead of holding Hamas and other terror groups accountable for looting and obstructing aid from reaching the population, it assigns 'indirect responsibility' to Israel for the actions of armed militants and terror organizations.'
UPI
6 hours ago
- UPI
Trump delivers immigration message on Scotland visit
1 of 3 | President Donald Trump played golf in Scotland Saturday morning, teeing it up at his Trump Turnberry golf resort ahead of meetings with European lawmakers and delivering a message after leaving the White House on Friday (pictured). Photo by Will Oliver/UPI | License Photo July 26 (UPI) -- President Donald Trump played golf in Scotland Saturday morning, teeing it up at his Trump Turnberry golf resort ahead of meetings with European lawmakers and delivering a message. "I say two things to Europe: Stop the windmills. You're ruining your countries. I really mean it, it's so sad. You fly over and you see these windmills all over the place, ruining your beautiful fields and valleys and killing your birds," Trump told reporters after arriving on Friday. "On immigration, you better get your act together. You're not going to have Europe any more," he said. Trump is scheduled to discuss trade during a Monday meeting with British Prime Minister Keir Starmer and Scottish First Minister John Swinney. He is also expected to meet with European Commission president Ursula von der Leyen during the four-day visit to Scotland. The delegation will start arriving Saturday and include European trade commissioner Maros Sefcovic, as well as von der Leyen, who Trump referred to as a "highly respected woman." U.S. officials and their EU counterparts are continuing attempts to reach a deal before an Aug. 1 deadline that will see 30% reciprocal tariffs take effect on all EU member states. The United States and Britain reached a deal in June on tariffs between the two countries, although Trump and Starmer were expected to iron out details during their meeting. Protestors demonstrated against Trump's visit in both Edinburgh and Aberdeen Saturday morning, including outside the Trump-owned golf course. He will also visit another of his privately-owned courses, Trump International Scotland in Aberdeenshire, during the trip. "We are really excited, across this whole weekend, there's so many campaign groups turning out in the streets, taking in action in their communities or at rallies like this. It's kind of like a carnival of resistance," demonstrator Anita Bhadani told the BBC outside of the U.S. Consulate General's office in Edinburgh Saturday, after helping to organize the Stop Trump Coalition. The coalition said its purpose is to "defeat the politics of Trumpism, and to promote an alternative, democratic vision of the world based on peace, social justice and international cooperation."
